Khurana S - Search Results

1

Comparison of SARS-CoV-2 Hyperimmune Immunoglobulins Following Infection Plus Vaccination vs Infection.

Bellusci L, Golding H, Khurana S. Bellusci L, et al. Among authors: khurana s. JAMA Netw Open. 2023 Aug 1;6(8):e2327307. doi: 10.1001/jamanetworkopen.2023.27307. JAMA Netw Open. 2023. PMID: 37540517 Free PMC article.

2

Identification of a linear peptide recognized by monoclonal antibody 2D7 capable of generating CCR5-specific antibodies with human immunodeficiency virus-neutralizing activity.

Khurana S, Kennedy M, King LR, Golding H. Khurana S, et al. J Virol. 2005 Jun;79(11):6791-800. doi: 10.1128/JVI.79.11.6791-6800.2005. J Virol. 2005. PMID: 15890918 Free PMC article.

3

CCR5 N-terminal region plays a critical role in HIV-1 inhibition by Toxoplasma gondii-derived cyclophilin-18.

Golding H, Khurana S, Yarovinsky F, King LR, Abdoulaeva G, Antonsson L, Owman C, Platt EJ, Kabat D, Andersen JF, Sher A. Golding H, et al. Among authors: khurana s. J Biol Chem. 2005 Aug 19;280(33):29570-7. doi: 10.1074/jbc.M500236200. Epub 2005 Jun 23. J Biol Chem. 2005. PMID: 15975927 Free article.

4

Human immunodeficiency virus (HIV) vaccine trials: a novel assay for differential diagnosis of HIV infections in the face of vaccine-generated antibodies.

Khurana S, Needham J, Mathieson B, Rodriguez-Chavez IR, Catanzaro AT, Bailer RT, Kim J, Polonis V, Cooper DA, Guerin J, Peterson ML, Gurwith M, Nguyen N, Graham BS, Golding H. Khurana S, et al. J Virol. 2006 Mar;80(5):2092-9. doi: 10.1128/JVI.80.5.2092-2099.2006. J Virol. 2006. PMID: 16474117 Free PMC article. Clinical Trial.

5

Novel approach for differential diagnosis of HIV infections in the face of vaccine-generated antibodies: utility for detection of diverse HIV-1 subtypes.

Khurana S, Needham J, Park S, Mathieson B, Busch MP, Nemo G, Nyambi P, Zolla-Pazner S, Laal S, Mulenga J, Chomba E, Hunter E, Allen S, McIntyre J, Hewlett I, Lee S, Tang S, Cowan E, Beyrer C, Altfeld M, Yu XG, Tounkara A, Koita O, Kamali A, Nguyen N, Graham BS, Todd D, Mugenyi P, Anzala O, Sanders E, Ketter N, Fast P, Golding H. Khurana S, et al. J Acquir Immune Defic Syndr. 2006 Nov 1;43(3):304-12. doi: 10.1097/01.qai.0000242465.50947.5f. J Acquir Immune Defic Syndr. 2006. PMID: 17019363 Free PMC article.

6

Antigenic fingerprinting of H5N1 avian influenza using convalescent sera and monoclonal antibodies reveals potential vaccine and diagnostic targets.

Khurana S, Suguitan AL Jr, Rivera Y, Simmons CP, Lanzavecchia A, Sallusto F, Manischewitz J, King LR, Subbarao K, Golding H. Khurana S, et al. PLoS Med. 2009 Apr 21;6(4):e1000049. doi: 10.1371/journal.pmed.1000049. Epub 2009 Apr 21. PLoS Med. 2009. PMID: 19381279 Free PMC article.

7

HIV-Selectest enzyme immunoassay and rapid test: ability to detect seroconversion following HIV-1 infection.

Khurana S, Norris PJ, Busch MP, Haynes BF, Park S, Sasono P, Mlisana K, Salim AK, Hecht FM, Mulenga J, Chomba E, Hunter E, Allen S, Nemo G, Rodriguez-Chavez IR; Women's Interagency HIV Study Collaborative Study Group; Margolick JB; Multicenter AIDS Cohort Study (MACS); Golding H. Khurana S, et al. J Clin Microbiol. 2010 Jan;48(1):281-5. doi: 10.1128/JCM.01573-09. Epub 2009 Nov 11. J Clin Microbiol. 2010. PMID: 19906903 Free PMC article.

8

Vaccines with MF59 adjuvant expand the antibody repertoire to target protective sites of pandemic avian H5N1 influenza virus.

Khurana S, Chearwae W, Castellino F, Manischewitz J, King LR, Honorkiewicz A, Rock MT, Edwards KM, Del Giudice G, Rappuoli R, Golding H. Khurana S, et al. Sci Transl Med. 2010 Jan 20;2(15):15ra5. doi: 10.1126/scitranslmed.3000624. Sci Transl Med. 2010. PMID: 20371470

9

Properly folded bacterially expressed H1N1 hemagglutinin globular head and ectodomain vaccines protect ferrets against H1N1 pandemic influenza virus.

Khurana S, Verma S, Verma N, Crevar CJ, Carter DM, Manischewitz J, King LR, Ross TM, Golding H. Khurana S, et al. PLoS One. 2010 Jul 12;5(7):e11548. doi: 10.1371/journal.pone.0011548. PLoS One. 2010. PMID: 20634959 Free PMC article. Retracted.

10

Bacterial HA1 vaccine against pandemic H5N1 influenza virus: evidence of oligomerization, hemagglutination, and cross-protective immunity in ferrets.

Khurana S, Verma S, Verma N, Crevar CJ, Carter DM, Manischewitz J, King LR, Ross TM, Golding H. Khurana S, et al. J Virol. 2011 Feb;85(3):1246-56. doi: 10.1128/JVI.02107-10. Epub 2010 Nov 17. J Virol. 2011. PMID: 21084473 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,083 results

Search Page